Epirubicin and etoposide combination chemotherapy to treat hepatocellular carcinoma patients: a phase II study-Reference-Cited by-同舟云学术

Epirubicin and etoposide combination chemotherapy to treat hepatocellular carcinoma patients: a phase II study

Published:1997-10 Issue:11 Volume:33 Page:1784-1788
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Bobbio-Pallavicini E.,Porta C.,Moroni M.,Bertulezzi G.,Civelli L.,Pugliese P.,Nastasi G.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference30 articles.

1. Time trends of liver cancer;Saracci;J Natl Cancer Inst,1980

2. Cancer statistics;Parker;CA Cancer J Clin,1996

3. Improving survival after resection of hepatocellular carcinoma: characteristics and current status of surgical treatment of primary liver cancer in Japan;Tobe,1993

4. Major hepatic resections for hepatoma in the West;Nagorney,1987

5. No treatment, resection and ethanol injection in hepatocellular carcinoma: a retro- spective analysis of survival in 391 patients with cirrhosis;Livraghi;J Hepatol,1995

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Network Pharmacology-Based Study on the Mechanism of Bushen-Jianpi Decoction in Liver Cancer Treatment;Evidence-Based Complementary and Alternative Medicine;2019-03-19

2. Efficacy and safety of epirubicin applied in transcatheter arterial chemoembolization for hepatocellular carcinoma: A meta-analysis;Journal of Cancer Research and Therapeutics;2018

3. Advances in systemic therapy for hepatocellular carcinoma;Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set;2017

4. Molecular targets of Chinese herbs: a clinical study of hepatoma based on network pharmacology;Scientific Reports;2016-05

5. Medical Therapy of HCC;Hepatocellular Carcinoma;2016